Stocks News

LAST PRICE
59.3879
TODAY'S CHANGE (%)
Trending Down-4.5021 (-7.0466%)

Bid / Lots
59.1200/ 7
Ask / Lots
59.4500/ 1
Open / Previous Close
63.5000 / 63.8900
Day Range
Low 59.1419
High 64.9600
52 Week Range
Low 22.8900
High 79.4899
Volume
522,320
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Yesterday
- Tempus to Participate in the Piper Sandler 36th Annual Healthcare Conference, from 8:30AM ET on Monday Nov 25, 2024 by Dow Jones
  8:30AM ET on Monday Nov 25, 2024 by Dow Jones
  Companies Mentioned: TEM
  
  Tempus to Participate in the Piper Sandler 36th Annual Healthcare Conference
  CHICAGO--(BUSINESS WIRE)--November 25, 2024--
  Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will participate in the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024, held in New York, New York.
- DJ S&P 500 Futures Climb In Premarket Trading; Bath & Body Works, Rocket Lab USA Lead, from 7:30AM ET on Monday Nov 25, 2024 by Dow Jones
  7:30AM ET on Monday Nov 25, 2024 by Dow Jones
  Companies Mentioned: BBWI, RKLB, SMCI, LLYVA, TEM, DOX
  
  This article was automatically generated by Barrons.com using technology from Automated Insights.
  
  With U.S. stock markets set to open in two hours, Bath & Body Works Inc. (BBWI) was up 12.0% in pre-market trading, and Rocket Lab USA Inc. (RKLB) was up 7.7%.
Nov 20, 2024
- Artificial Intelligence (AI) Reshaping Healthcare Industry with Unimaginable Potential, from 8:45AM ET on Wednesday Nov 20, 2024 by Dow Jones
  8:45AM ET on Wednesday Nov 20, 2024 by Dow Jones
  Companies Mentioned: MDT, AVAI, CLOV, TEM, TDOC
  
  New advancements in the AiBLE(TM) ecosystem build upon the company's commitment to procedural innovation and execution, and include the following: O-arm(TM) 4.3 software, which introduces advanced navigation volumes, dose reduction, and enhanced image confirmation. With this release, Medtronic now offers the industry's longest 3D scan length for cone-beam CT images, which allows surgeons to capture additional spine levels in one scan and streamline their workflow. O-arm(TM) is the first and only intraoperative imager that uses AI, with 70% less radiation dose compared to the standard protocol, while maintaining image quality. Medtronic Implant Resolution (MIR) further enhances decision-making by reducing metal artifacts around select screws, enabling confident final screw placement.
Nov 12, 2024
- DJ Tempus AI Price Target Raised to $70.00/Share From $40.00 by Piper Sandler, from 11:19AM ET on Tuesday Nov 12, 2024 by Dow Jones
  11:19AM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: TEM
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/TEM/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 12, 2024 11:19 ET (16:19 GMT)
- Tempus Molecular Profiling Integration Now Available Through Flatiron's OncoEMR(R), from 8:30AM ET on Tuesday Nov 12, 2024 by Dow Jones
  8:30AM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: TEM
  
  Tempus Molecular Profiling Integration Now Available Through Flatiron's OncoEMR(R)
  CHICAGO--(BUSINESS WIRE)--November 12, 2024--
  Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the collaboration with Flatiron Health, a leading healthtech company dedicated to expanding the possibilities of point of care solutions in oncology, to integrate its comprehensive genomic testing directly into Flatiron's cloud-based Electronic Medical Record (EMR) platform, OncoEMR(R) through the Molecular Profiling Integration (MPI). This integration will provide oncologists with seamless access to Tempus' suite of testing options, enhancing their ability to deliver personalized cancer care.

Nov 22, 2024
- European Equities Traded in the US as American Depositary Rise in Friday Trading, Up Over 1% for Week, from 11:04AM ET on Friday Nov 22, 2024 by MT Newswires
  11:04AM ET on Friday Nov 22, 2024 by MT Newswires
  Companies Mentioned: ING, BBVA, TRIB, AMRN, OPRA, GNFT, AKTX, BNTX, AZN, SLN, TCBP, ASND, ADAP, SAN, BDRX, EDAP
Nov 19, 2024
- UBS Raises Price Target on Intra-Cellular Therapies to $87 From $79, Maintains Neutral Rating, from 10:56AM ET on Tuesday Nov 19, 2024 by MT Newswires
  10:56AM ET on Tuesday Nov 19, 2024 by MT Newswires
  Companies Mentioned: ITCI
- Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences, from 8:00AM ET on Tuesday Nov 19, 2024 by Dow Jones
  8:00AM ET on Tuesday Nov 19, 2024 by Dow Jones
  Companies Mentioned: ITCI
Nov 18, 2024
- European Equities Traded in the US as American Depositary Rise in Monday Trading, from 11:21AM ET on Monday Nov 18, 2024 by MT Newswires
  11:21AM ET on Monday Nov 18, 2024 by MT Newswires
  Companies Mentioned: NTZ, NVO, TEF, SQNS, GRFS, AMRN, OPRA, AKTX, MREO, SLN, EVAX, BP, TCBP, ASND, ADAP, BDRX
Nov 15, 2024
- DJ Ascendis Pharma Is Maintained at Buy by TD Cowen, from 1:48PM ET on Friday Nov 15, 2024 by Dow Jones
  1:48PM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: ASND
- DJ Ascendis Pharma Price Target Maintained With a $181.00/Share by Wedbush, from 1:11PM ET on Friday Nov 15, 2024 by Dow Jones
  1:11PM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: ASND
- European Equities Traded in the US as American Depositary Drop in Friday Trading, Down 2.8% for Week, from 11:09AM ET on Friday Nov 15, 2024 by MT Newswires
  11:09AM ET on Friday Nov 15, 2024 by MT Newswires
  Companies Mentioned: BBVA, LYG, PUK, ARGX, AKTX, MREO, BCYC, BNTX, EVAX, BTI, TCBP, DBVT, ASND, CLLS, SAN, BDRX
- DJ Ascendis Pharma Is Maintained at Outperform by Oppenheimer, from 11:03AM ET on Friday Nov 15, 2024 by Dow Jones
  11:03AM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: ASND
- DJ Ascendis Pharma Price Target Maintained With a $170.00/Share by Cantor Fitzgerald, from 9:53AM ET on Friday Nov 15, 2024 by Dow Jones
  9:53AM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: ASND
- --Oppenheimer Adjusts Ascendis Pharma A/S Price Target to $180 From $190, Maintains Outperform Rating, from 9:14AM ET on Friday Nov 15, 2024 by MT Newswires
  9:14AM ET on Friday Nov 15, 2024 by MT Newswires
  Companies Mentioned: ASND

Tempus AI Inc
NASDAQ:TEMUnited States

Search Criteria

Yesterday

Tempus to Participate in the Piper Sandler 36th Annual Healthcare Conference, from 8:30AM ET on Monday Nov 25, 2024 by Dow Jones

DJ S&P 500 Futures Climb In Premarket Trading; Bath & Body Works, Rocket Lab USA Lead, from 7:30AM ET on Monday Nov 25, 2024 by Dow Jones

Nov 20, 2024

Artificial Intelligence (AI) Reshaping Healthcare Industry with Unimaginable Potential, from 8:45AM ET on Wednesday Nov 20, 2024 by Dow Jones

Nov 12, 2024

DJ Tempus AI Price Target Raised to $70.00/Share From $40.00 by Piper Sandler, from 11:19AM ET on Tuesday Nov 12, 2024 by Dow Jones

Tempus Molecular Profiling Integration Now Available Through Flatiron's OncoEMR(R), from 8:30AM ET on Tuesday Nov 12, 2024 by Dow Jones

Peers Headlines

Nov 22, 2024

European Equities Traded in the US as American Depositary Rise in Friday Trading, Up Over 1% for Week, from 11:04AM ET on Friday Nov 22, 2024 by MT Newswires

Nov 19, 2024

UBS Raises Price Target on Intra-Cellular Therapies to $87 From $79, Maintains Neutral Rating, from 10:56AM ET on Tuesday Nov 19, 2024 by MT Newswires

Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences, from 8:00AM ET on Tuesday Nov 19, 2024 by Dow Jones

Nov 18, 2024

European Equities Traded in the US as American Depositary Rise in Monday Trading, from 11:21AM ET on Monday Nov 18, 2024 by MT Newswires

Nov 15, 2024

DJ Ascendis Pharma Is Maintained at Buy by TD Cowen, from 1:48PM ET on Friday Nov 15, 2024 by Dow Jones

DJ Ascendis Pharma Price Target Maintained With a $181.00/Share by Wedbush, from 1:11PM ET on Friday Nov 15, 2024 by Dow Jones

European Equities Traded in the US as American Depositary Drop in Friday Trading, Down 2.8% for Week, from 11:09AM ET on Friday Nov 15, 2024 by MT Newswires

DJ Ascendis Pharma Is Maintained at Outperform by Oppenheimer, from 11:03AM ET on Friday Nov 15, 2024 by Dow Jones

DJ Ascendis Pharma Price Target Maintained With a $170.00/Share by Cantor Fitzgerald, from 9:53AM ET on Friday Nov 15, 2024 by Dow Jones

--Oppenheimer Adjusts Ascendis Pharma A/S Price Target to $180 From $190, Maintains Outperform Rating, from 9:14AM ET on Friday Nov 15, 2024 by MT Newswires